Showing results (1201-1210 of 2,812) with videos related to
Sort By:
Pageof 282
Expert Opinion on Drug Safety|October 30, 2015
Renal impairment in patients with chronic hepatitis C treated with first generation protease inhibitorsDorota Kozielewicz, Dorota Dybowska, Kornelia Karwowska, et al.Expert Opinion on Drug Safety|May 24, 2016
Safety of gefitinib in non-small cell lung cancer treatmentEmily Han-Chung Hsiue, Jih-Hsiang Lee, Chia-Chi Lin, et al.Expert Opinion on Drug Safety|May 28, 2016
Serenoa repens, selenium and lycopene to manage lower urinary tract symptoms suggestive for benign prostatic hyperplasiaAndrea Russo, Paolo Capogrosso, Giovanni La Croce, et al.Expert Opinion on Drug Safety|May 10, 2016
The safety of pharmacological treatment options for lupus nephritisAlba Velo-García, Eleana Ntatsaki, David IsenbergExpert Opinion on Drug Safety|May 10, 2016
The safety of tocolytics used for the inhibition of preterm labourCallum D Lamont, Jan Stener Jørgensen, Ronald F LamontExpert Opinion on Drug Safety|May 4, 2016
A safety evaluation of brentuximab vedotin for the treatment of Hodgkin lymphomaEunhye Oak, Nancy L BartlettExpert Opinion on Drug Safety|October 9, 2014
Umeclidinium for treating COPD: an evaluation of pharmacologic properties, safety and clinical useRajapriya Manickam, Amit Asija, Wilbert S AronowExpert Opinion on Drug Safety|November 18, 2014
Safety considerations when using anti-TNFα therapy to treat Crohn's diseaseCristiano Pagnini, Kristen O Arseneau, Fabio CominelliExpert Opinion on Drug Safety|November 20, 2014
Multiple sclerosis and pregnancy prescriptionsPatricia K CoyleExpert Opinion on Drug Safety|August 21, 2014
Cardiovascular risk associated with testosterone-boosting medications: a systematic review and meta-analysisGiovanni Corona, Elisa Maseroli, Giulia Rastrelli, et al.Pageof 282